NIH researchers identify key factor that stimulates brain cancer cells to spread
Researchers funded by the National Institutes of Health have found that the activity of a protein in brain cells helps stimulate the spread of an aggressive brain cancer called glioblastoma multiforme (GBM). In a move toward therapy, the researchers showed that a small designer protein can block this activity and reduce the spreading of GBM cells grown in the laboratory. GBM is the most lethal form of brain cancer, with about half of patients expected to die within a year of diagnosis. GBM is named for the fact that the cancerous cells have properties of support cells in the brain called glial cells. Rather than simply growing in a single tumor mass, GBM cells tend to migrate throughout the brain, making it difficult to remove them surgically. As the cells spread and multiply, they also tend to become resistant to radiation and chemotherapy.
"Interventions to control the spreading of glioblastoma multiforme have the potential to slow the clinical course of the disease and improve overall survival rates," says Jane Fountain, Ph.D., a program director at NIH's National Institute of Neurological Disorders and Stroke (NINDS). NINDS funded the new study through an initiative that encourages research on why brain tumor cells are so highly invasive and how to therapeutically target these cells.
The study's senior author is Susann Brady-Kalnay, Ph.D., a neuroscientist at Case Western Reserve University in Cleveland and an expert on the development of the retina. For years, she has studied how cells migrate to their proper places in the developing retina. In particular, she studied how this process is regulated by cell adhesion molecules – proteins at a cell's surface that can keep the cell stuck to its surroundings, or help the cell move. She has shown that a cell adhesion molecule called PTPmu is required for retinal cell migration. Investigating the role of PTPmu in GBM dispersal was a logical extension, she says.
"We know that cell adhesion is important for development, and that there are many parallels between what happens during development and what happens in cancer," says Dr. Brady-Kalnay. For instance, she notes there is some evidence that cancer cells have turned back the developmental clock and reverted to an embryonic stem cell-like state.
In their new study published in Cancer Research, Dr. Brady-Kalnay and her team report that in GBM cancer cells, the PTPmu protein is cut into fragments, a process known as proteolysis. One might expect that the loss of intact PTPmu would simply cause the cells to detach from their surroundings. However, the fragments also appear to act as signals that stimulate the cells to move and to thrive outside of their normal surroundings.
The researchers found the PTPmu fragments in GBM tumors that had been surgically removed from patients and in GBM cells grown in the laboratory. Next, they examined how these fragments affected the migration of GBM cells in a petri dish. They observed that adding more of the intact protein to the cells or treating the cells with a chemical inhibitor of proteolysis reduced the cells' ability to migrate.
Finally, they showed that it is possible to suppress the effect of the fragments, even without restoring the intact PTPmu protein. This last experiment built upon a collaboration between Dr. Brady-Kalnay and Frank Longo, M.D., chair of the neurology department at Stanford University School of Medicine. The two researchers had previously designed a very small protein, or peptide, capable of attaching to PTPmu and blocking its effects on retinal cell migration. Here, Dr. Brady-Kalnay and her team tested this peptide in GBM cells, and found that it blocked their ability to migrate, too.
The peptide cannot currently be used to treat GBM, because it would be broken down rapidly if it was injected directly into the body. The researchers hope to develop injectable compounds that mimic the peptide, and to test those compounds in animal models of GBM.
- Protein link may be key to new treatment for aggressive brain tumorTue, 22 Dec 2009, 13:52:41 EST
- Indirubin -- Component Of Chinese herbal remedy might block brain tumor's spreadTue, 12 Jul 2011, 17:36:10 EDT
- Brain tumors: Tissue stem cell turning into tumor stem cellThu, 1 Apr 2010, 10:26:49 EDT
- Gene vital to brain's stem cells implicated in deadly brain cancerMon, 17 Aug 2009, 12:44:53 EDT
- Molecule Nutlin-3a activates a signal inducing cell death and senescence in primary brain tumorsWed, 20 Apr 2011, 10:35:19 EDT
- Key Factor That Stimulates Brain Cancer Cells To Spread Identifiedfrom Science DailyThu, 20 Aug 2009, 0:14:24 EDT
- NIH researchers identify key factor that stimulates brain cancer cells to spreadfrom Science CentricWed, 19 Aug 2009, 9:07:14 EDT
- Gene Vital To Brain's Stem Cells Implicated In Deadly Brain Cancerfrom Science DailyWed, 19 Aug 2009, 0:14:14 EDT
- NIH researchers identify key factor that stimulates brain cancer cells to spreadfrom Biology News NetTue, 18 Aug 2009, 20:21:25 EDT
- Researchers identify key factor that stimulates brain cancer cells to spreadfrom PhysorgTue, 18 Aug 2009, 14:14:11 EDT
Latest Science NewsletterGet the latest and most popular science news articles of the week in your Inbox! It's free!
Learn more about
Check out our next project, Biology.Net
From other science news sites
Popular science news articles
- Seismic gap outside of Istanbul
- The contribution of particulate matter to forest decline
- Voices may not trigger brain's reward centers in children with autism, Stanford/Packard study shows
- Mars had oxygen-rich atmosphere 4,000 million years ago
- Unusual supernova is doubly unusual for being perfectly normal
- Even with defects, graphene is strongest material in the world
- Detection of the cosmic gamma ray horizon: Measures all the light in the universe since the Big Bang
- Genetic engineering alters mosquitoes' sense of smell
- Allosaurus fed more like a falcon than a crocodile, new study finds
- 'Popcorn' particle pathways promise better lithium-ion batteries